CTRI/2018/03/012720招募中未知
Evaluation of efficacy of low dose Tadalafil - Tadalafil for PBS
Dr Gajanan Bhat0 个研究点目标入组 0 人开始时间: 待定最近更新:
试验速览
- 阶段
- 未知
- 状态
- 招募中
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •All the patients presenting with painful bladder syndrome who give their informed consent to participate in the study
排除标准
- •3.Mental disorders
- •4.Altered LFT/RFT
- •5.Patient on treatment for bladder pain syndrome
- •6.Patients with diagnosis of UTI, Malignancy etc
研究者
相似试验
进行中（未招募）
4 期
The effect of tadalafil in the treatment of erectile dysfunction in patients with chronic renal failureerectile dysfunctionend stage renal diseasehaemodialysiskidney transplantRenal DialysisKidney TransplantationErectile DysfunctionKidney Failure, ChronicTCTR20220310008rology-Nephrology Research Center of Shahid Beheshti University of Medical Sciences45
尚未招募
4 期
A study to compare the beneficial effect and safety of tadalafil compared to sildenafil in pulmonary hypertensive patients due to lung diseaseCTRI/2024/06/069470Midhun Sakravarthy J
进行中（未招募）
1 期
A study in children with Pulmonary Arterial Hypertension to assess the safety of Tadalafil as the dose increases, as well as how the drug works in the bodyPulmonary Arterial HypertensionEUCTR2011-001873-24-ESEli Lilly and Company19
进行中（未招募）
1 期
A study in children with Pulmonary Arterial Hypertension to assess the safety of Tadalafil as the dose increases, as well as how the drug works in the bodyPulmonary Arterial HypertensionMedDRA version: 18.1Level: PTClassification code 10064911Term: Pulmonary arterial hypertensionSystem Organ Class: 10038738 - Respiratory, thoracic and mediastinal disordersEUCTR2011-001873-24-PLEli Lilly and Company24
进行中（未招募）
1 期
A study in children with Pulmonary Arterial Hypertension to assess the safety of Tadalafil as the dose increases, as well as how the drug works in the bodyMedDRA version: 17.1Level: PTClassification code 10064911Term: Pulmonary arterial hypertensionSystem Organ Class: 10038738 - Respiratory, thoracic and mediastinal disordersPulmonary Arterial HypertensionEUCTR2011-001873-24-GBEli Lilly and Company19